Part 2/13:

Jade, a 32-year-old veterinarian, exemplifies the personal decisions many face regarding COVID-19 vaccination. Despite the widespread availability of mRNA vaccines, she opted for Sinovac, citing her comfort with the traditional inactivated virus technology. Unlike Pfizer or Moderna, which utilize messenger RNA to instruct cells to produce viral proteins, Sinovac employs a more conventional approach, using killed virus particles to stimulate immunity.